Transdermal Patches Market Analysis North America, Europe, Asia, Rest of World (ROW) - US, Germany, UK, China, Japan - Size and Forecast 2024-2028

Transdermal Patches Market Forecast 2024-2028

The Global Transdermal Patches Market size is forecast to increase by USD 2.00 billion, at a CAGR of  5.65% between 2023 and 2028.

There has been a growing demand for non-invasive drug delivery methods across the world. As patients and healthcare providers increasingly look for alternatives to traditional oral medications and invasive procedures, transdermal patches have emerged as a preferred option due to their convenience, effectiveness, and patient-friendly nature. In addition, one of the primary reasons driving the demand for non-invasive drug delivery methods is the desire to minimize discomfort and inconvenience associated with conventional routes of administration, such as injections or oral tablets. Furthermore, transdermal patches offer a painless and hassle-free method of drug delivery, eliminating the need for needles or frequent dosing while providing sustained release of medication over an extended period. Hence, such factors are positively impacting the market.

What will be the Size of the Market During the Forecast Period?

To learn more about this report, Download Report Sample

Segmentation by Application, End-user, and Geography Analysis

The market encompasses a wide array of factors influencing drug delivery and healthcare practices. Key elements such as healthcare facility costs play a crucial role in market dynamics, impacting the affordability and accessibility of transdermal medications. Pharmaceuticals drive innovation in patch formulations, incorporating advanced electronic systems for controlled dosing and enhanced efficacy. Technological developments in drug formulations have led to the emergence of transdermal patches as a preferred option for managing chronic illnesses and pain-related conditions. These patches, including analgesic patches, offer non-invasive methods of drug delivery, reducing reliance on traditional injections and addressing concerns like medication failure. Amidst challenges like the opioid epidemic, transdermal patches provide a safer alternative for pain management, ensuring controlled dosing and prolonged therapeutic effects. They are particularly beneficial for the elderly population and individuals with conditions like diabetes and hypertension. 

Application Analysis

The pain management segment is estimated to witness significant growth during the forecast period. Transdermal patches are transforming pain management on a global scale, providing a targeted and convenient approach to alleviating various types of pain. In addition, these patches are designed to administer analgesic medications directly through the skin, providing systemic absorption and prolonged relief. Furthermore, commonly utilized drugs in transdermal patches include opioids, Non-steroidal anti-inflammatory drugs (NSAIDs), lidocaine, and other pain-relieving agents.

Get a glance at the market contribution of various segments Download PDF Sample

The pain management segment was the largest segment and was valued at USD 1.76 billion in 2018. Moreover, the global market for pain management is being driven by several factors. In addition, one significant driver is the increasing prevalence of chronic pain conditions worldwide, such as arthritis, neuropathic pain, and musculoskeletal disorders. Furthermore, the aging population and rising healthcare expenditures are contributing to the market expansion. In addition, technological advancements in patch design, including improved adhesives and drug delivery systems, are further fueling market growth by expanding the range of medications that can be administered transdermally. Hence, such factors are fuelling the growth of this segment which in turn drives the market during the forecast period.

End-user Analysis

The global market is witnessing significant growth in the homecare segment, fuelled by various factors and catering to diverse end-users. In addition, transdermal patches provide a convenient and non-invasive method for administering medications, making them particularly suitable for individuals receiving care in a home setting. Moreover, one of the primary drivers of the global market in the homecare segment is the rising trend of self-administered therapies. In addition, patients with chronic conditions, such as pain, hormonal imbalances, or neurological disorders, can conveniently apply transdermal patches at home, reducing the need for frequent visits to healthcare facilities and enhancing overall patient autonomy. Hence, such factors are fuelling the growth of this segment which in turn drives the market during the forecast period.

Regional Analysis

For more insights about the market share of various regions Download PDF Sample now!

North America is estimated to contribute 56% to the growth of the global market during the forecast period. Technavio’s analysts have elaborately explained the regional trends and drivers that will shape the market during the forecast period. North America stands as a significant leader in the global market, characterized by robust growth and significant market share. In addition, the region encompasses countries such as the US, Canada, and Mexico, with the US being the largest market contributor. Moreover, one of the primary drivers of the market in North America is the increasing prevalence of chronic diseases and conditions such as pain, hormonal imbalances, cardiovascular diseases, and neurological disorders. In addition, transdermal patches offer a convenient and effective method of drug delivery for managing these conditions, driving their adoption among healthcare providers and patients. Furthermore, among middle school and high school students, e-cigarettes are the most prominently used tobacco product from the same source, followed by cigarettes, cigars, smokeless tobacco, hookahs, nicotine pouches, heated tobacco products, and pipe tobacco. Hence, such factors are driving the market in North America during the forecast period.

Buy Full Report Now

Key Market Players 

Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market. The report also includes detailed analyses of the competitive landscape of the market and information about 20 market companies, including:

Boehringer Ingelheim International GmbH: The company offers transdermal patches through its Skinfusion transdermal delivery system such as Twirla AG200-15, AG200-ER (SmP), AG200-ER and AG890.

Alvogen Iceland ehf, Endo International Plc, Hisamitsu Pharmaceutical Co. Inc., IontoPatch, Johnson and Johnson Services Inc., Lead Chemical Co. Ltd., Luye Pharma Group Ltd., Medherant Ltd., Mundipharma International Ltd., Nitto Denko Corp., Novartis AG, Purdue Pharma LP, Sparsha Pharma International Pvt. Ltd., Teva Pharmaceutical Industries Ltd., Viatris Inc., AdhexPharma SAS, Agile Therapeutics Inc., Bayer AG, and Evernow Inc.

Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.

Market Dynamics and Customer Landscape

The Market is driven by several key factors. Rising healthcare facility costs push for innovative and cost-effective pharmaceuticals like transdermal patches. Advancements in electronic technologies enable precise drug formulations targeting chronic illnesses. Analgesic patches and non-invasive methods offer effective pain management amid concerns over medication failure and the opioid epidemic. Challenges include transdermal drug delivery system recalls and ensuring adhesive patch efficacy on diverse skin types. Despite these, technological developments and adhesive advancements pave the way for improved drug delivery in treating diabetes, hypertension, and pain-related conditions in the elderly population. Our researchers analyzed the market research and growth data with 2023  as the base year, along with the key market growth analysis, trends, and challenges. A holistic analysis of drivers, trends, and challenges will help companies refine their marketing strategies to gain a competitive advantage. 

Significant  Trends

The development of microneedle patches for enhanced drug delivery efficiency is an emerging trend in the market. The development of microneedle patches represents a significant trend in the global market, providing improved drug delivery efficiency and expanding the scope of transdermal therapy. In addition, microneedle patches consist of arrays of microscopic needles that penetrate the outer layer of the skin, creating temporary micropores that allow for efficient drug delivery into the underlying tissue layers.

Moreover, one of the key advantages of microneedle patches is their ability to bypass the skin's natural barrier more effectively compared with traditional transdermal patches. Therefore, this enables enhanced delivery of both small and large molecules, including proteins, peptides, and vaccines, which may have limited permeability through the intact skin. Thus, microneedle patches offer the potential for improved bioavailability and therapeutic efficacy of drugs delivered transdermal. Hence, such factors are driving the market during the forecast period.

Major Challenges

Stringent regulatory approvals for transdermal drug delivery systems by government bodies are a major challenge hindering the market. Biologics, medications, and medical devices are subject to strict regulations that are integrated in an attempt to minimize unfavorable user reactions. As a result, it causes delays in market entry and impedes innovation.

For instance, a transdermal drug delivery system (TDDS) must pass a stringent set of tests, such as biomechanical testing, animal testing, and clinical trials, before the Food and Drug Administration (FDA) approves it for use in the market. In addition, the lengthy regulatory procedure may cause TDDSs' release from the market to be delayed, reducing the opportunity for first-mover advantage and restricting the market's potential growth for transdermal skin patches. Hence, such factors are hindering the market during the forecast period.

Buy Now Full Report

Key Market Customer Landscape

The market report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their growth strategies.

 Customer Landscape

Segment Overview

The market report forecasts market growth by revenue at global, regional & country levels and provides an analysis of the latest trends and growth opportunities from 2018 to 2028. 

• Application Outlook
  • Pain management
  • Central nervous system disorders
  • Hormonal application
  • Cardiovascular diseases
  • Others
• End-user Outlook
  • Homecare
  • Hospitals and clinics
• Region Outlook
  • North America
    • The U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • France
    • Rest of Europe
  • Asia
    • China
    • India
  • Rest of the World (ROW)
    • Australia
    • Argentina
    • Brazil

Market Analyst Overview

The market is driven by several key factors, including the rising prevalence of chronic illnesses such as heart disease, cancer, diabetes, and hypertension. Advancements in technological developments have led to the emergence of innovative drug delivery systems like analgesic patches and contraceptive patches. These patches offer non-invasive and painless methods for medication delivery, particularly beneficial for patients with a BMI of 30 kg/m2 and above. Moreover, the market addresses issues such as medication failure, skin irritation, and adhesive performance through formulation improvements and skin barriers.

Moreover, pharmaceutical companies and drug delivery companies play a crucial role in developing multi-layer drug-in-adhesive segments, ensuring controlled dosing and prolonged therapeutic effects. The opioid epidemic has also spurred the demand for transdermal patches as a safer alternative to pain management techniques. Healthcare facilities are increasingly adopting these patches to reduce costs associated with traditional injections and to cater to the needs of the elderly population. Overall, advancements in patch technology and delivery mechanisms continue to shape the Market, offering promising solutions for various health conditions.

Furthermore, the Market is a dynamic sector influenced by various factors, including transdermal drug delivery system recalls and the need to address formulation issues effectively. One of its key advantages lies in offering non-invasive methods for medication administration, reducing patient discomfort, and enhancing treatment adherence. These adhesive patches deliver medication directly into the bloodstream, bypassing the gastrointestinal system and avoiding the dose of medicine breakdown associated with oral dosage forms. Technological advances have led to the development of innovative patches capable of administering antiretroviral drugs for conditions like HIV infection, along with managing pain-related conditions effectively. Moreover, transdermal patches are particularly beneficial for patients with a BMI 30 kg/m2 and above, offering convenient application on areas such as the abdomen, buttock, or upper torso.

Market Scope
Report Coverage	Details
Page number	159
Base year	2023
Historic period	2018-2022
Forecast period	2024-2028
Growth momentum & CAGR	Accelerate at a CAGR of 5.65%
Market Growth 2024-2028	USD 2.00 billion
Market structure	Fragmented
YoY growth 2023-2024(%)	4.87
Regional analysis	North America, Europe, Asia, and the Rest of the World (ROW)
Performing market contribution	North America at 56%
Key countries	US, Germany, UK, China, and Japan
Competitive landscape	Leading Vendors, Market Positioning of Vendors, Competitive Strategies, and Industry Risks
Key companies profiled	Alvogen Iceland ehf, Boehringer Ingelheim International GmbH, Endo International Plc, Hisamitsu Pharmaceutical Co. Inc., IontoPatch, Johnson and Johnson Services Inc., Lead Chemical Co. Ltd., Luye Pharma Group Ltd., Medherant Ltd., Mundipharma International Ltd., Nitto Denko Corp., Novartis AG, Purdue Pharma LP, Sparsha Pharma International Pvt. Ltd., Teva Pharmaceutical Industries Ltd., Viatris Inc., AdhexPharma SAS, Agile Therapeutics Inc., Bayer AG, and Evernow Inc.
Market dynamics	Parent market analysis, Market forecasting, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, and Market condition analysis for the forecast period.
Customization purview	If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

Download Sample PDF at your Fingertips

What are the Key Data Covered in this Market Research Report?

• CAGR of the market during the forecast period
• Detailed information on factors that will drive the growth of the between 2024 and 2028
• Precise estimation of the size and its contribution to the market in focus on the parent market
• Detailed analysis of customer landscape covering Diver of price sensitivity, Adoption of the lifecycle, and key purchase criteria 
• Companies landscape comparing criticality of inputs and factors of differentiation
• Exclusive Matrix on companies' position and classification
• Accurate predictions about upcoming market trends and changes in consumer behavior
• Growth of the market across North America, Europe, Asia, and the Rest of the World (ROW)
• Thorough market growth and forecasting analysis of the market’s competitive landscape and detailed information about companies
• Comprehensive analysis of factors that will challenge the growth of companies

We can help! Our analysts can customize this market research report to meet your requirements. Get in touch